Health  Vol.6 No.14 , July 2014
Issues in the Care and Treatment of HCV/HIV Co-Infection for Key Populations in Resource-Constrained Settings
Abstract: Globally, the epidemic of hepatitis virus infection is increasing in the context of common viral transmission routes with the Human Immunodeficiency Virus (HIV). Thus, co-infection with both hepatitis virus and HIV is becoming a common occurrence, particularly for key populations. Studies of key populations, people who inject drugs, sex workers, transgendered individuals and men having sex with men, report high levels of illicit drug and/or alcohol use along with limited access to health care and medical treatment. Without the medical management of co-occurring substance use disorders and hepatitis C virus (HCV) infection, a significant proportion of this population with HCV/HIV co-infection will progress to chronic liver disease then subsequently end-stage liver disease. Thus, access to comprehensive care and treatment, including HCV testing with subsequent care and treatment of acute/chronic HCV infection is essential to address the global burden of disease. Increased efforts are needed globally to address the barriers to comprehensive care and treatment for key populations with HCV/HIV co-infection.
Cite this paper: Kresina, T. , Lubran, R. and Clark, H. (2014) Issues in the Care and Treatment of HCV/HIV Co-Infection for Key Populations in Resource-Constrained Settings. Health, 6, 1803-1815. doi: 10.4236/health.2014.614212.

[1]   World Hepatitis Alliance (2008) World Hepatitis Day 2008.

[2]   World Health Organization (WHO) (2010) Global Hepatitis Programme.

[3]   World Health Organization (WHO) (2012) Prevention & Control of Viral Hepatitis Infection: Framework for Global Action.

[4]   World Health Organization (WHO) (2013) Global Policy Report on the Prevention and control of Viral Hepatitis in Member States.

[5]   Gupta, P. (2013) Hepatitis C Virus and HIV Type 1 Co-Infection. Infectious Disease Report, 5, e7.

[6]   Wechsberg, W.M., Golin, C., El-Bassel, N., Hopkins, J. and Zule, W. (2012) Current Interventions to Reduce Sexual Risk Behaviors and Crack Cocaine Use among HIV-Infected Individuals. Current HIV/AIDS Report, 9, 385-393.

[7]   Friedman, S.R., Mateu-Gelabert, P. and Sandoval, M. (2011) Group Sex Events amongst Non-Gay Drug Users: An Understudied Risk Environment. International Journal on Drug Policy, 22, 1-8.

[8]   Zuckerman, M.D. and Boyer, E.W. (2012) HIV and Club Drugs in Emerging Adulthood. Current Opinions in Pediatrics, 24, 219-224.

[9]   Alter, M.J. (2011) HCV Routes of Transmission: What Goes around Comes Around. Seminars in Liver Diseases, 31, 340-346.

[10]   Green, K.E. and Feinstein, B.A. (2012) Substance Use in Lesbian, Gay and Bisexual Populations: An Update on Empirical Research and Implications for Treatment. Psychology and Addiction Behavior, 26, 265-278.

[11]   Matthews, G.V. and Dore, G.J. (2008) HIV and Hepatitis C Coinfection. Journal of Gastroenterology and Hepatology, 23, 1000-1008.

[12]   Taylor, L.E., Swan, T. and Mayer, K.H. (2012) HIV Coinfection with Hepatitis C Virus: Evolving Epidemiology and Treatment Paradigms. Clinical Infectious Diseases, 55, S33-S42.

[13]   Nelson, P.K., Mathers, B.M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D. and Degenhardt, L. (2011) Global Epidemiology of Hepatitis B and Hepatitis C in People Who Inject Drugs: Results of Systematic Reviews. Lancet, 378, 571-573.

[14]   Johnston, L., Saumtall, A., Corceal, S., Mahadoo I. and Oodally, F. (2011) High HIV and Hepatitis C Prevalence amongst Injection Drug Users in Mauritius: Findings from a Population Size Estimate and Respondent Driven Sampling Survey. International Journal on Drug Policy, 22, 252-258.

[15]   Panda, S., Roy, T., Pahari, S., Mehraa, J., Sharma, N., Singh, G., Singh, J., Joseph, F., Singh, S. and Sharma, N.M. (2013) Alarming Epidemics of Human Immunodeficiency Virus and Hepatitis C Virus among Injection Drug Users in the Northwestern Bordering State of Punjab, India: Prevalence and Correlates. International Journal on Sexual Transmitted Diseases and AIDS.

[16]   de Lédinghen, V., Barreiro, P., Foucher, J., Labarga, P., Castéra, L., Vispo, M.E., et al. (2008) Liver Fibrosis on Account of Chronic Hepatitis C Is More Severe in HIV-Positive than HIV-Negative Patients Despite Antiretroviral Therapy. Journal of Viral Hepatitis, 15, 427-433.

[17]   El-Bassel, N., Shaw, S.A., Dasgupta, A. and Strathdee, S.A. (2014) Drug Use as a Driver of HIV Risks: Re-Emerging and Emerging Issues. Current Opinion in HIV and AIDS, 9, 150-155.

[18]   Abdala, N., Hasen, N.B., Toussova, O.V., Krasnoselskikh, T.V., Kozlov, A.P. and Heimer, R. (2012) Age at First Alcoholic Drink as a Predictor of Current HIV Sexual Risk Behaviors among a Sample of Injection Drug Users (IDUs) and Non-IDUs Who Are Sexual Partners of IDUs, in St. Petersburg, Russia. AIDS Behavior, 16, 1597-1604.

[19]   Prakask, O., Mason, A., Luftig, R.B. and Bautista, A.P. (2002) Hepatitis C Virus (HCV) and Human Immunodeficiency Virus Type 1 (HIV-1) Infections in Alcoholics. Frontiers in Biological Sciences, 7, e286-e300.

[20]   Danta, M. and Rodger, A.J. (2011) Transmission of HCV in HIV-Positive Populations. Current Opinion in HIV and AIDS, 6, 451-458.

[21]   Wandeler, G., Gsponer, T., Bregenzer, A., Gunthard, H.F., Clerc, O., Calmy, A., Stockle, M., Bernasconi, E., Furrer, H., Rauch, A. and the Swiss HIV Cohort Study (2012) Hepatitis C Virus Infections in the Swiss HIV Cohort Study: A Rapid Evolving Epidemic. Clinical Infectious Diseases, 55, 1408-1416.

[22]   Gambotti, L. (2005) Acute Hepatitis C Infection in HIV Positive Men Who Have Sex With Men in Paris, Francis 2001-2004. European Surveillance, 10, 115-117.

[23]   Matthews G.V., Hellard, M., Kaldor, J. and Dore, G. (2007) Further Evidence of HCV Sexual Transmission among HIV-Positive Men Who Have Sex With Men: Response to Danta et al. AIDS, 21, 2112-2113.

[24]   Yaphe, S., Bozinoff, N., Kyle, R., Shivkumar, S., Pai, N.P. and Klein, M. (2012) Incidence of Acute Hepatitis C Virus Infection among Men Who Have Sex with Men with and without HIV Infection: A Systematic Review. Sexually Transmitted Infections, 88, 558-564.

[25]   Morano, J.P., Gibson, B.A. and Altice, F.L. (2013) The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting. PLoS ONE, 8, e64321.

[26]   Lea, T., Lee, E., Mao, L., de Wit, J. and Holt, M. (2013) HIV and Hepatitis C Virus Co-Infection among Men Who Have Sex with Men in Sydney, and Associations with Sexual and Drug Use Practices. Sexual Health, 10, 448-451.

[27]   Mahony, A.A., Donnan, E.J., Lester, R.A., Doyle, J.S., Knox, J., Tracy, S.L., Bowden, S. and Sasadeusz, J.J. (2013) Beyond Injecting Drug Use: Investigation of a Victorian Cluster of Hepatitis C among HIV-Infected Men Who Have Sex with Men. Medical Journal of Australia, 198, 210-214.

[28]   Gamage, D.G., Read, T.R., Bradshaw, C.S., Hocking, J.S., Howley, K., Chen, M.Y. and Farley, C.K. (2011) Incidence of Hepatitis-C among HIV Infected Men Who have Sex with Men (MSM) Attending a Sexual Health Service: A Cohort Study. BMC Infectious Diseases, 11, 39.

[29]   Beyer, C., Sullivan, P., Sanchez, J., Baral, S.D., Collins, C., Witz, A.L., Altman, D., Trapence, G. and Mayer, K. (2013) The Increase in Global HIV Epidemics in MSM. AIDS, 27, 2665-2678.

[30]   Li, X.F., Lu, H.Y., Cox, C., Zhao, Y.J., Xia, D.Y., Sun, Y.M., He, X., Xiao, Y., Ruan, Y., Jia, Y.J. and Shao, Y. (2014) Changing the Landscape of the HIV Epidemic among MSM in China: Results from Three Consecutive Respondent-Driven Sampling Surveys from 2009-2011. BioMedical Research International, 2014, Article ID 563517.

[31]   Boesecke, C. and Rockstroh, J.K. (2012) Acute Hepatitis C in Patients with HIV. Seminars in Liver Diseases, 32, 130- 137.

[32]   Boesecke, C. and Vogel, M. (2011) HIV and Hepatitis C Co-Infection: Acute HCV Therapy. Current Opinion in HIV AIDS, 6, 459-464.

[33]   Boesecke, C. and Rockstroh, J.K. (2011) Treatment of Acute Hepatitis C Infection in HIV-Infected Patients. Current Opinion in HIV & AIDS, 6, 278-284.

[34]   Breyer, C., Sullivan, P.S., Sanchez, J., Dowdy, D., Altman, D., Trapence, G., Collins, C., Katabira, E., Kazatchkine, M, Sidibe, M. and Mayer, K.H. (2012) A Call to Action for Comprehensive HIV Services for Men Who Have Sex with Men. The Lancet, 380, 424-438.

[35]   Stroumsa, D. (2014) The State of Transgender Health Care: Policy, Law and Medical Frameworks. American Journal of Public Health, 104, e31-e38.

[36]   Wolf, R.C., Cheng, A.S., Kapesa, L. and Castor, D. (2013) Building the Evidence Base for Urgent Action: HIV Epidemiology and Innovative Programming for Men Who Have Sex with Men in Sub-Saharan Africa. Journal of the International AIDS Society, 16, 18903.

[37]   Newman, P.A., Lee, S.J., Roungprakhon, S. and Tepjan, S. (2012) Demographic and Behavioral Correlates of HIV Risk among Men and Transgender Women Recruited from Gay Entertainment Venues and Community-Based Organizations in Thailand: Implications for HIV Prevention. Prevention Science, 13, 483-492.

[38]   Li, Y., Baker, J.J., Korostyshevskiy, V.R., Slack, R.S. and Plankey, M.W. (2012) The Association of Intimate Partner Violence, Recreational Drug Use with HIV Seroprevalence among MSM. AIDS Behavior, 16, 491-498.

[39]   Wei, C., Guadamuz, T.E., Lim, S.H., Huang, Y. and Koe, S. (2012) Pattern and Level of Illicit Drug Use among Men Who Have Sex with Men in Asia. Drug and Alcohol Dependence, 120, 246-249.

[40]   Luchters, S., Giebel, S., Syengo, M., Lango, D., King’ola, N., Temmerman, M. and Chersich, M.F. (2011) Use of AUDIT, and Measures of Drinking Frequency and Patterns to Detect Association between Alcohol and Sexual Behavior in Male Sex Workers in Kenya. BMC Public Health, 11, 384-390.

[41]   Baral, S., Beyrer, C., Muessig, K., Poteat, T., Wirtz, A.L., Decker, M.R., Sherman, S.G. and Kerrigan, D. (2012) Burden of HIV among Female Sex Workers in Low-Income and Middle-Income Countries: A Systematic Review and Meta-Analysis. The Lancet Infectious Diseases, 12, 538-549.

[42]   Papworth, E., Ceesay, N., An, L., Thiam-Niagoin, M., Ky-Zerbo, O., Holland, C., Frame, F.M., Grosso, A., Diouf, D. and Baral, S.D. (2013) Epidemiology of HIV among Female Sex Workers, Their Clients, Men Who Have Sex with Men and People Who Inject Drugs in West and Central Africa. Journal of the International AIDS Society, 16, 18751.

[43]   Shannon, K., Goldenberg, S.M., Deering, K.N. and Strathdee, S.A. (2014) HIV Infection among Female Sex Workers in Concentrated and High Prevalence Epidemics: Why a Structural Dominants Framework Is Needed. Current Opinion in HIV & AIDS, 9, 174-182.

[44]   Baral, S., Todd, C.S., Aumakham, B., Lloyd, J., Delegchoimbol, A. and Sabin, K. (2013) HIV among Female Sex Workers in the Central Asian Republics, Afghanistan, and Mongolia: Contexts and Convergence with Drug Use. Drug and Alcohol Dependence, 132, S13-S16.

[45]   Cainelli, F. (2013) Hepatitis C Virus and Human Immunodeficiency Virus Transmission Routes: Differences and Similarities. World Journal of Hepatology, 5, 234-236.

[46]   Frederick, T., Burian, P., Terrault, N., Cohen, M., Augenbraun, M., Young, M., et al. (2009) Factors Associated with Prevalent Hepatitis C Infection among HIV-Infected Women with No Reported History of Injection Drug Use: The Women’s Interagency HIV Study (WIHS). AIDS Patient Care and STDs, 23, 915-923.

[47]   El-Bassel, N., Wechsberg, W.M. and Shaw, S.A. (2012) Dual Risk and Vulnerabilities among Women Who Use or Inject Drugs: No Single Prevention Strategy Is the Answer. Current Opinion in HIV & AIDS, 7, 326-331.

[48]   Li, Q., Li, X. and Stanton, B. (2010) Alcohol Use among Female Sex Workers and Male Clients: An Integrative Review of Global Literature. Alcohol and Alcoholism, 45, 188-199.

[49]   Lyons, T., Kerr, T., Duff, P., Feng, C. and Shannon, K. (2014) Youth, Violence and Non-Injection Drug Use: Nexus of Vulnerabilities among Lesbian and Bisexual Sex Workers. AIDS Care, 26, 1090-1094.

[50]   Marhall, B.D., Wood, E., Shoveller, J.A., Patterson, T.L., Montaner, J.S. and Kerr, T. (2011) Pathways to HIV Risk and Vulnerability among Lesbian, Gay, Bisexual, and Transgendered Methamphetamine Users: A Multi-Cohort Gender-Based Analysis. BMC Public Health, 11, 20.

[51]   Nemoto, T., Iwamoto, M., Sakata, M., Perngparn, U. and Areesantichai, C. (2012) Social and Cultural Contexts of HIV Risk Behaviors among Thai Female Sex Workers in Bangkok, Thailand. AIDS Care, 25, 613-618.

[52]   Chersich, M.F., Luchters, S.M., Malonza, I.M., Mwarogo, P., King’ola, N. and Temmerman M. (2007) Heavy Episodic Drinking among Kenyan Female Sex Workers Is Associated with Unsafe Sex, Sexual Violence and Sexually Transmitted Infections. International Journal of Sexually Transmitted Diseases and AIDS, 18, 764-769.

[53]   Chersich, M.F., Luchters, S., Ntaganira, I, .Gerbase, A., Lo, Y.R., Scorgie, F. and Steen, R. (2013) Priority Interventions to Reduce HIV Transmission in Sex Work Settings in Sub-Saharan Africa and Delivery of These Services. Journal of the International AIDS Society, 16, 17980.

[54]   Mumtaz, G.R., Weiss, H.A., Thomas, S.L., Riome, S., Setayesh, H., Riedner, G., Semini, I., Tawil, O., Akala, F.A., Wilson, D. and Abu-Raddad, L.J. (2014) HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis. PLoS Medicine, 11, Article ID: e1001663.

[55]   Needle, R., Kroeger, K., Belani, H., Achrekar, A., Parry, C.D. and Dewing, S. (2008) Sex, Drugs, and HIV: Rapid Assessment of HIV Risk Behaviors among Street-Based Drug Using Sex Workers in Durban, South Africa. Social Science Medicine, 67, 1447-1455.

[56]   Parry, C.D., Petersen, P., Carney, T., Dewing, S. and Needle, R. (2008) Rapid Assessment of Drug Use and Sexual HIV Risk Patterns among Vulnerable Drug Using Populations in Cape Town, Durban and Pretoria, South Africa. SAHARA Journal, 5, 113-119.

[57]   Parry, C.D., Plüddemann, A., Louw, A. and Leggett, T. (2004) The 3-Metros Study of Drugs and Crime in South Africa: Findings and Policy Implications. The American Journal of Drug and Alcohol Abuse, 30, 167-185.

[58]   Wechsberg, W.M., Wu, L.T., Zule, W.A., Parry, C.D., Browne, F.A., Luseno, W.K., Kline, T. and Gentry, A. (2009) Substance Abuse, Treatment Needs and Access among Female Sex Workers and Non-Sex Workers in Pretoria, South Africa. Substance Abuse Treatment, Prevention, and Policy, 4, 1-11.

[59]   Raut, D.K., Pal, D. and Das, A. (2003) A Study of HIV/STD Infections amongst Commercial Sex Workers in Kolkata (India) Part II: Sexual Behavior, Knowledge and Attitude towards STD/HIV Infections. Journal of Communicable Diseases, 35, 182-187.

[60]   Medhi, G.K., Mahanta, J., Kermode, M., Paranjape, R.S., Adhikary, R., Phukan, S.K. and Ngully, P. (2012) Factors Associated with History of Drug Use among Female Sex Workers (FSW) in a High Prevalence State of India. BMC Public Health, 12, 273.

[61]   Chen, Y., Li, X., Zhang, C., Hong, Y., Zhou, Y. and Liu, W. (2013) Alcohol Use and Sexual Risks: Use of Alcohol Use Disorders Identification Test (AUDIT) among Female Sex Workers in China. Health Care of Women International, 34, 122-138.

[62]   Wang, H., Brown, K.S., Wang, G., Ding, G., Zang, C., Wang, J., Reilly, K.H., Chen, H. and Wang, N. (2011) Knowledge of HIV Seropositvity Is a Predictor for Illicit Drug Use: Incidence of Drug Use Initiation among Female Sex Workers in a High HIV-Prevalence Area of China. Drug and Alcohol Dependence, 117, 226-232.

[63]   Safika, I., Timothy, P., Johnson, T.P. and Levy, J.A. (2011) A Venue Analysis of Predictors of Alcohol Use Prior to Sexual Intercourse among Female Sex Workers in Senggigi, Indonesia. International Journal of Drug Policy, 22, 49-55.

[64]   Johnston, L.G., Vaillant, T.C., Dolores, Y. and Vales, H.M. (2013) HIV, Hepatitis B/C and Syphilis Prevalence and Risk Behaviors among Gay, Transsexuals and Men Who Have Sex with Men, Dominican Republic. International Journal of Sexually Transmitted Diseases and AIDS, 24, 313-321.

[65]   Carobene, M., Bolcic, F., Farias, M.S., Quarleri, J. and ávila, M.M. (2014) HIV, HBV, and HCV Molecular Epidemiology among Trans (Transvestites, Transsexuals, and Transgender) Sex Workers in Argentina. Journal of Medical Virology, 86, 64-70.

[66]   Nuttbrock, L., Hwahng, S., Bockting, W., Rosenblum, W., Mason, M., Macri, M. and Becker, J. (2009) Lifetime Risk Factors for HIV/Sexually Transmitted Infections among Male-to-Female Transgender Persons. JAIDS Journal of the Acquired Immune Deficiency Syndrome, 52, 417-421.

[67]   Altaf, A., Zahidie, A. and Agha, A. (2012) Comparing Risk Factors of HIV among Hijra Sex Workers in Larkana and Other Cities of Pakistan: An Analytical Cross Sectional Study. BMC Public Health, 12, 279.

[68]   Reback, C.J. and Fletcher, J.B. (2013) HIV Prevalence, Substance Use, and Sexual Risk Behaviors among Transgender Women Recruited Through Outreach. AIDS & Behavior, 18, 1359-1367.

[69]   Deacon, R.M., Mooney-Somers, J., Treloar, C. and Maher, L. (2013) At the Intersection of Marginalised Identities: Lesbian, Gay, Bisexual and Transgender People’s Experience of Injecting Drug Use and Hepatitis C Seroconversion. Health and Social Care in the Community, 21, 402-410.

[70]   Taylor, L.E., Swan, T. and Matthews, G.V. (2013) Management of Hepatitis C Virus/HIV Coinfection among People Who Use Drugs in the Era of Direct-Acting Antiviral-Based Therapy. Clinical Infectious Diseases, 57, S118-S124.

[71]   Herando, V., Prerez-Cachafeiro, S., Lewden, C., Gonzalez, J., Segura, F., Oteo, J.A., et al. (2012) All-Cause and Liver-Related Mortality in HIV Positive Subjects Compared to the General Population: Differences by Co-Infection. Journal of Hepatology, 57, 743-751.

[72]   van der Helm, J., Geskus, R., Sabin, C., Meyer, L., del Amo, J., Chêne, G., et al. (2013) Effect of HCV Infection on Cause-Specific Mortality after HIV Seroconversion, before and after 1997. Gastroenterology, 144, 751-760.

[73]   Graham, C.S, Baden, L.R., Yu, E., Mrus, J.M., Carnie, J., Heeren, T. and Koziel, M.J. (2001) Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta-Analysis. Clinical Infectious Diseases, 33, 562-569.

[74]   De Lédinghen, V., Barreiro, P., Foucher, J., Labarga, P., Castéra, L., Vispo, M.E., Bernard, P.H., Martin-Carbonero, L., Neau, D., García-Gascó, P., Merrouche, W. and Soriano, V. (2008) Liver Fibrosis on Account of Chronic Hepatitis C Is More Severe in HIV-Positive than HIV-Negative Patients Despite Antiretroviral Therapy. Journal of Viral Hepatitis, 15, 427-433.

[75]   Weber, R., Sabin, C.A., Friis-Moller, N., Reiss, P., El-Sadr, W.M., Kirk, O., Dabis, F., Law, M.G., Pradier, C., De Wit, S., Akerlund, B., Calvo, G., Monforte, A., Rickenbach, M., Ledergerber, B., Phillips, A.N. and Lundgren, J.D. (2006) Liver-Related Deaths in Persons Infected with the Human Immunodeficiency Virus: The D:A:D Study. Archives of Internal Medicine, 166, 1632-1641.

[76]   Scorgie, F., Nakato, D., Harper, E., Richter, M., Maseko., Nare, P., Smit, J. and Chersich, M. (2013) “We Are Despised in the Hospitals”: Sex Workers’ Experience of Accessing Health Care in Four African Countries. Culture, Health & Sexuality, 15, 450-465.

[77]   Deering, K.N., Kerr, T., Tyndall, M.W., Montaner, J.S., Gibson, K., Irons, L. and Shannon, K. (2011) A Peer-Led Mobile Outreach Program and Increased Utilization of Detoxification and Residential Drug Treatment among Female Sex Workers Who Use Drugs in a Canadian Setting. Drug and Alcohol Dependence, 113, 46-54.

[78]   Soriano, V., Puoti, M., Sulkowski, M., Mauss, S., Cacoub, P., Cargnel, A., Dieterich, D., Hatzakis, A. and Rockstroh, J. (2004) Care of Patients with Hepatitis C and HIV Co-Infection. AIDS, 18, 1-12.

[79]   Mehta, S.H., Genberg, B.L., Astemborski, J., Kavasery, R., Kirk, G.D., Vlahov, D., Strathdee, S. and Thomas, D.L. (2008) Limited Uptake of Hepatitis C Treatment among Injection Drug Users. Journal of Community Health, 33, 126-133.

[80]   Bruce, R.D., Kresina, T.F. and McCance-Katz, E. (2010) Medication Assisted Treatment and HIV/AIDS: Issues in the Diagnosis, Care and Treatment of HIV-Infected Drug Users. AIDS, 24, 331-340.

[81]   Kresina, T.F., Lubran, R., Clark, H.W. and Cheever, L.W. (2012) Substance Assisted Treatment, HIV/AIDS and the Continuum of Response for People Who Inject Drugs. Advances in Preventive Medicine, 2012, Article ID 541489.

[82]   Shapiro, B., Coffa, D. and McCance-Katz, E.F. (2013) A Primary Care Approach to Substance Misuse. American Family Physician, 88, 113-121.

[83]   National Institute on Drug Abuse (NIDA) (1999) Principles of Drug Addiction Treatment, A Research Based Guide. NIH Publication 99-4180.

[84]   Ghodse, H. (2002) Drug and Addictive Behavior: A Guide to Treatment. 3rd Edition, Cambridge University Press, Cambridge.

[85]   Verrico, C.D., Haile, C.N., Newton, T.F., Kosten, T.R. and De La Garza, R. (2013) Pharmacotherapeutics for Substance-Use Disorders: A Focus on Dopaminergic Medications. Expert Opinion on Investigative Drugs, 22, 1549-1568.

[86]   Hyman, S.E. and Malenka, R.C. (2001) Addiction and the Brain: The Neurobiology of Compulsion and Its Persistence. National Reviews in Neuroscience, 2, 695-703.

[87]   Swift, R., Oslin, D.W., Alexander, M. and Forman, R. (2011) Adherence Monitoring in Naltrexone Pharmacotherapy Trials: A Systematic Review. Journal of Studies in Alcohol and Drugs, 72, 1012-1018.

[88]   Kresina, T.F., Bruce, R.D., Pirard, S., Mulvey, K.V, Huesca, R.S. and Lubran, R. (2012) International Expansion of the Use of Pharmacotherapies for the Treatment of Opioid Dependence. Clinical and Experimental Pharmacology, S5, 1.

[89]   Bachireddy, C., Soule, M.C., Izenberg, J.M., Dvoryak, S., Dumchev, K. and Altice, F.L. (2014) Integration of Health Services Improves Multiple Healthcare Outcomes among HIV-Infected People Who Inject Drugs in Ukraine. Drug and Alcohol Dependence, 134, 106-114.

[90]   Yen, Y.F., Yen, M.Y., Su, L.W, Li, L.H., Chuang, P., Jiang, X.R. and Deng, C.Y. (2012) Prevalences and Associated Risk Factors of HCV/HIV Co-Infection and HCV Mono-Infection among Injecting Drug Users in a Mono-Infection among Injecting Drug Users in a Methadone Maintenance Treatment Program in Taipei, Twain. BMC Public Health, 12, 1066-1073.

[91]   Zhuang, X., Liang, Y., Chow, E.P., Wang, Y., Wilson, D.P. and Zhang, L. (2012) HIV and HCV Prevalence among Entrants to Methadone Maintenance Treatment Clinics in China: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 12, 130.

[92]   Zhuang, X., Wang, Y., Chow, E, P., Liang, Y., Wilson, D.P. and Zhang, L. (2012) Risk Factors Associated with HIV/ HCV Infection among Entrants in Methadone Maintenance Treatment Clinics in China: A Systematic Review and Meta-Analysis. Drug and Alcohol Dependence, 126, 286-295.

[93]   Bao, Y.P., Du, C., Lu, H.Y., Lian, Z., Qiu, Y., Mu, Y., Yan, S.Y. and Liu, Z.M. (2012) The Investigation of HIV and HCV Infection and Risk Factors Among Opiate Drug Users in Beijing, China. The American Journal of Drug and Alcohol Abuse, 38, 140-145.

[94]   Xia, Y.H, Chen, W., Tucker, J.D., Wang, C. and Ling, L. (2013) HIV and Hepatitis C Virus Test Uptake at Methadone Clinics in Southern China: Opportunities for Expanding Detection of Bloodborne Infections. BMC Public Health, 13, 899-907.

[95]   Malta, M., da Costa, M.R. and Bastos, F.L. (2013) The Paradigm of Universal Access to HIV-Treatment and Human Rights Violation: How Do We Treat HIV-Positive People Who Use Drugs. Current HIV/AIDS Report, 11, 52-62.

[96]   Puoti, M., Rossotti, R., Travi, G., Panzeri, C., Morreale, M., Chiari, E., Cocca, G., Orso, M. and Moioli, M.C. (2013) Optimizing Treatment in HIV/HCV Coinfection. Digestive & Liver Diseases, 45, S355-S362.

[97]   Stricker, S.M., Fox, K.A., Baggaley, R., Negussie, E., de Pee, S., Grede, N. and Bioem, M.W. (2013) Retention in Care and Adherence to ART Are Critical Elements of HIV Care Interventions. AIDS Behavior, Epub Ahead of Print.

[98]   Allen, J., Smith, C. and Bhagani, S. (2014) Will Antireroviral Therapy Reduce HIV-Related Liver Risk? Current Opinion in HIV & AIDS, 9, 48-53.

[99]   Murray, M., Hogg, R.S., Lima, V.D., May, M.T., Moore, D.M., Abgrall, S., Bruyand, M., D’Arminio, Monforte, A., Tural, C., Gill, M.J., Harris, R.J., Reiss, P., Justice, A., Kirk, O., Saag, M., Smith, C.J., Weber, R., Rockstroh, J., Khaykin, P., Sterne, J.A. and the Antiretroviral Therapy Cohort Collaboration (ART-CC) (2012) The Effect of Injecting Drug Use History on Disease Progression and Death among HIV-Positive Individuals Initiating Combination Antiretroviral Therapy: Collaborative Cohort Analysis. HIV Medicine, 13, 89-97.

[100]   Hernandez, M.D. and Sherman, K.E. (2011) HIV/Hepatitis Coinfection Natural History and Disease Progression. Current Opinion in HIV & AIDS, 6, 478-482.

[101]   Lincoln, D., Petoumenos, K., Dore, G.J. and Australian HIV Observational Database (2003) HIV/HBV and HIV/HCV Confection, and Outcomes Following Highly Active Antiretroviral Therapy. HIV Medicine, 4, 241-249.

[102]   Easterbrooke, P., Sands, A. and Harmanci, H. (2012) Challenges and Priorities in the Management of HIV/HBV and HIV/HCV Coinfection in Resource-Limited Settings. Seminars in Liver Disease, 32, 147-157.

[103]   US Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents.

[104]   (2014) European AIDS Clinical Society. Version 7.02.

[105]   Ghany, M.G., Strader, D.B., Thomas, D.L. and Seeff, L.B. (2009) Diagnosis, Management, and Treatment of Hepatitis C: An Update. Hepatology, 49, 1335-1374.

[106]   Zeremski, M., Martinez, A.D. and Talal, A.H. (2014) Management of Hepatitis C Virus in HIV-Infected Patients in the Era of Direct-Acting Antivirals. Clinical Infectious Diseases, 58, 880-882.

[107]   Soriano, V., Labarga, P., Vispo, E., Ferández-Montero, J.V. and Barreiro, P. (2012) Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era. Infectious Diseases Clinics of North America, 26, 931-948.

[108]   Fierer, D.S., Dieterich, D.T., Mullen, M.P., Branch, A.D., Uriel, A.J., Carriero, D.C., van Seggelen, W.O., Hijdra, R.M., Cassagnol, D.G. and the New York Acute Hepatitis C Surveillance Network (2013) Telaprevir in the Treatment of Acute Hepatitis C Virus Infection in HIV-Infected Men. Clinical Infectious Diseases, 58, 873-879.

[109]   Luetkemeyer, A.F., Havlir, D.V. and Currier, J.S. (2012) Complications of HIV Disease and Antiretroviral Therapy. Topics in Antiviral Medicine, 20, 48-60.

[110]   Rodriguez-Torres, M. (2013) Focus on Drug Interactions: The Challenge of Treating Hepatitis C Virus Infection with Direct-Acting Antiviral Drugs in the HIV Positive Patient. Current Opinion in Infectious Diseases, 26, 50-57.

[111]   Salmon-Ceron, D., Arvieux, C., Bourliere, M., Cacoub, P., Halfon, P., Lacombe, K., Pageaux, G.P., Pialoux, G., Piroth, L., Poizot-Martin, I., Rosenthal, E. and Pol, S. (2013) Use of First-Generation HCV Protease Inhibitors in Patients Co-Infected by HIV and HCV Genotype 1. Liver International, 34, 869-889.

[112]   Coco, B., Caraceni, P., Aghemo, A., Bitetto, D., Bruno, R., Ciancio, A., Marzioni, M., Petta, S., Rendina, M. and Valenti, L. (2014) Triple Therapy with First-Generation Protease Inhibitors for Patients with Genotype 1 Chronic Hepatitis C: Recommendations of the Italian Association for the Study of the Liver (AISF). Digestive Liver Diseases, 46, 18-24.

[113]   AIDSMAP (2014) Sofosbuvir & Ribavirin Cures 75% of Genotype 1 HIV/HCV Co-Infected Patients. Report from the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014), Boston.